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Wound healing is a perfectly coordinated cascade of cellular, molecular, and biochemical events which interact in tissue
reconstitution. Chronic diseases such as pressure ulcers (PU) and diabetes mellitus (DM) are considered risk factors for wound
healing. Patients with such diseases often have higher sepsis, infection, and complication rates, since they have revascularization
inhibition and low growth factor expression. Thus, latex biomembrane (LBM), a biocompatible material, derived from the latex
of the rubber tree (Hevea brasiliensis) appears to create tendencies as an angiogenic-inducing tissue healing agent and as
biomaterial, resulting from its structural qualities and its low cost when compared to conventional treatments. Therefore, this
work aims at summarizing the results, experiments, and scientific findings that certify or recommend the use of LBM as a new
technique to be applied effectively in the treatment of wounds. An integrative review was held in the BIREME, LILACS, Burns,
MEDLINE, PubMed, and SciELO databases, from 2000 to 2016, using the following descriptors: “healing,” “diabetes mellitus,”
“wounds,” and “latex membrane.” As a result, 600 experiments (out of 612) presented satisfactory results; however, 33% of the
cases received explicit recommendations, 11% required more studies on the subjects, and 1% was denied. On the other hand,
half of the studies did not expressly endorse its use, despite presenting satisfactory results. The LBM was characterized as a good
therapeutic alternative in cases of wounds, including chronic diseases, such as diabetes mellitus and PU, due to its relevant
potential for wound healing stimulation, acceleration of cell tissue mending and revascularization, or the reestablishment of
angiogenic functions (creation of new blood vessels). The LBM was also confirmed to be safe as a biocompatible material whose
structural qualities (elasticity, adaptability, impermeability, and possibility of suture), devoid of toxicity, allowed interaction
between tissues and presented no hypersensitivity inducer and no antimicrobial effect.
1. Introduction
Wound treatment has been evolving since 3,000 BC, when
hemorrhagic wounds were treated with cauterization. There
are evidences of the use of tourniquets that date back to 400
BC, while suture is from the 3rd century BC. In the Middle
Ages, with the creation of gunpowder, wounds became a
more serious matter. Nowadays, chronic wounds caused
by pressure ulcers (PU), vascular ulcers, and neuropathic
ulcers (diabetes mellitus (DM) and leprosy) associated
with complications in ambulatory therapeutic efficiency
are quite challenging to treat [1–3].
The most common chronic wounds in the American
population are chronic ulcers in the lower limbs (80 to
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90%), and its etiology is venous stasis, at 5% arterial insuffi-
ciency and 2% neuropathy [4]. According to information
from the International Diabetes Federation (IDF), 80% of
the people with diabetes live in low- and middle-income
countries. For example, in South and Central America, there
were 26 million patients diagnosed with diabetes in 2017, and
it is predicted that this number will increase to 42 million
until 2045 [5]. Specifically in Brazil, the amount of patients
diagnosed with diabetes has increased 61.8% between the
years of 2006 and 2016 [6]. The World Health Organization
(WHO) informs that roughly 422 million of adults have
diabetes and that 2% of the population of the planet have
complications in healing chronic wounds [7].
In Costa et al.’s survey [8] on the cost for PU treatment,
treatment material costs were calculated around R$
10,989.00 per year per patient. When combining this cost
to the information we have on the treatment of
DM-originated wounds, it is stated that about R$ 59.4
billion/year is spent on it [3].
Scientific communities have been making multiple efforts
in order to test new techniques and discoveries that aim at
contributing to the improvement of this scenario. In 1996,
the latex biomembrane (LBM) emerged as a promising
element, because besides it being quite affordable, it also
has physical and chemical characteristics that aid in healing
with its neoangiogenic activity [9, 10].
LBM is a polyisoprene derivative, made of rubber latex
(Hevea brasiliensis), a whitish secretion (also called “coagulated
milky sap”) produced by the stem of the tree when it undergoes
an incision in the bark, called “sangria.” This natural latex is
composed of rubbery, nongummy hydrocarbon particles sus-
pended in an aqueous serum phase, in which there is an
occurrence of (on average) 36% hydrocarbons, 1.6% carbohy-
drates, 1.4% protein, 1% neutral lipids, 0.6% glycolipids plus
phospholipids, 0.5% inorganic components, 58.5% water,
and 0.4% other substances. Therefore, Hevea brasiliensis latex
is a compound cytoplasmic system in which rubber particles
and nonrubbery particles are dispersed in an aqueous cytosol
phase [3, 11].
Mrue et al. [12] emphasize that the great secret for LBM’s
angiogenesis (formation of new blood vessels) stimulation
was only discovered because the polymer was not obtained
through the traditional vulcanization method, which
involves temperatures of 110°C to 125°C. In order to obtain
the polymer, latex was collected with ammonia as the sole
preservative, and centrifugation was then used to diminish
its protein content, principally allergenic proteins. A sulfur
composition was then added as the sole recovery agent; then,
the latex was polymerized at low temperatures in a glass mold
and then sterilized in ethylene oxide [3]. The result of this
process is a biomembrane. The biomembrane is thin and
elastic, has micropores that resemble human skin, and is easy
to maneuver, as can be seen in Figure 1.
These characteristics help out in the wound repair
process, particularly at the granulation tissue growth phase.
This process can be divided into spatially and temporarily
overlapping phases: (1) coagulation, (2) inflammation, (3)
formation of granulation tissue (proliferative phase), and
(4) remodeling or scar formation phase [14]. The endothelial
cells are digested by molecules that make cell-cell and
cell-matrix interactions. The endothelial cells are grouped
and make a protrusion through the fragments of the basal
membrane, at first forming solid rows of cells. Endothelial
cells then begin to introduce cytoplasmic vacuoles, which
are fused together at first among themselves and then with
the neighboring cells, giving rise to new light. Factors by
macrophages (factor of angiogenesis-derived macrophages),
mast cells (heparin), platelets (platelet-derived growth
factor, transforming growth factor beta), and fibroblasts
(fibroblast growth factor) have all presented a positive effect
on angiogenesis [14–16].
Latex, one of the materials used for the production of
the therapeutic insoles features the advantages of its low
market price, low pathogen transmission risk, neovascular-
ization and tissue regeneration properties, and wide
clinical-social applicability. Latex is extracted from the
rubber tree Hevea brasiliensis, and it is both a healing sub-
stance and defense mechanism for this organism [17].
Numerous research which used natural latex as an implant
on different tissues have presented satisfactory results,
which motivate the development of new works in the area
[13, 17–20]. Regarding this scope, personalized insoles
made with natural latex have been used as an important
tool for the reduction of plantar pressure in the treatment
of patients with a diabetic foot [12, 17]. The research of
Duff A. C. indicates that one in four of young diabetics
(age 11-24) has increased plantar pressure and/or plantar
blister (lump, tissue thickening—lat. plantar callus) [13,
20, 21]. The impacted areas are high-risk areas for devel-
opment of some variety of foot conditions in adulthood.
Biomechanical alterations increase the occurrence of devel-
opment of fissures, blisters, and deformities. Limited range
of motion in joints is commonly seen in diabetic patients
[21]. Natural latex biomembrane (NLB) was proven to
be an effective material in the reconstruction of the peri-
cardium of dogs [22], in iatrogenic defects in the abdom-
inal wall of rats [23], and in a neoangiogenic inductor in
rabbit corneas [24, 25]. According to Balabanian et al.
[26], granules of natural latex implanted inside the alveo-
lar sockets of rats immediately after dental extraction dem-
onstrated biocompatibility and become integrated with the
alveolar bone, simultaneously accelerating bone formation
Figure 1: Latex biomembrane. This figure is reproduced from
Ribeiro et al. [13], public domain.
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undergoes and playing an important role in the healing
process. Domingos et al. [27] have also demonstrated NLB’s
biocompatibility as a matrix for bladder augmentation in rab-
bits. The researchers affirm that it allows a progressive
ingrowth of all layers of the bladder wall, raising epithelium
and muscle regeneration without postoperative urinary leak-
age and with a slow rate of stone formation [25, 27].
Patients with chronic wounds come across multiple diffi-
culties in this stage, such as vascular problems, atherosclerosis
predisposition, renal insufficiency, and poor infection
response [28, 29]. Diabetes mellitus (DM) is a set of metabolic
alterations, whose main characteristic is the decompensation
of glucose levels in the bloodstream, characterized as hypergly-
cemia or hypoglycemia [30]. There is a raised risk of infection
due to the diabetic’s inability to control the bacterial coloniza-
tion site, and obviously, if the situation is not controlled, it will
lead to a vicious circle, which will fatally evolve to the amputa-
tion stage. That being said, early intervention is essential in the
wound-healing treatment’s success [31, 32].
Candido ([33], p. 80) makes the following approach:
antibiotics can produce toxic effects and inhibit healing
and thus should be administered only when there is infec-
tion, and anti-inflammatories cause microcirculation vaso-
constriction, reducing the inflammatory response and
collagen synthesis, and should be used only when there is
pain or inflammation. This analysis is important because
otherwise there is a bigger probability of delay in the
healing process and the rise of resistant bacteria.
It is at this healing stage that the LBM can contribute the
most. From 1998 to 2000, this peptide- and angiogenesis-
inducing material started being successfully used in some
hospitals in the treatment of chronic wound patients suffer-
ing from diabetes. In some cases, the biomaterial is sprinkled
on the wound, and a substance very similar to the VEGF
(Vascular Endothelial Growth Factor) is released, rebuilding
veins and arteries and carrying fuel so that the wound site can
heal [12]. Therefore, this article intends to contribute to these
studies through the gathering and exposition of scientific evi-
dences on the successful use of LBM in the healing process, as
well as its recommendations and prohibitions.
2. Materials and Methods
We conducted a study to review the scientific literature using
the following databases: BIREME, LILACS, Burns, MEDLINE,
PubMed, and SciELO. Publications from 2000 to 2016 were
selected with the following keywords: “healing,” “diabetes mel-
litus,” “wounds,” and “latex biomembrane.” The inclusion cri-
teria for the selection of publications were the publications in
their entirety, being published and/or indexed in these data-
bases in the period of 2000 to 2016, and that they addressed
the issues of use of the rubber tree (Hevea brasiliensis)
latex-derived biomembrane and being of free access. Articles
published before 2000, articles that have not addressed the
rubber tree (Hevea brasiliensis) latex-derived biomembrane,
articles that presented DM-related issues that were not corre-
lated to LBM, and those discussing issues related to healing
and wounds without the use of the latex biomembrane were
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Figure 2: Main results obtained with the use of LBM in direct application, checked in the publication-surveyed 1 frame.
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3. Results
Table 1 presents the results of the integrative review of the
scientific literature. With the works selected through the
inclusion and exclusion criteria, there were 18 publications
found, among which were selected tests with 611 subjects
that varied between humans, animals, and laboratory tests.
4. Discussion
Out of the 18 publications found, 17 papers presented sat-
isfactory results with tests on 600 subjects (263 in humans,
1 laboratory test, and 336 in animals), i.e., 98% of cases
with LBM implementation presented satisfactory results.
Sousa et al. [36], in 12 experiments with dogs, do not
recommend the LBM for preperitoneal inguinoplasty due
to encasement formation. However, the authors state that
the biomembranes keep influencing the process of scarring
with no fibrosis, no bruising, and no seroma and infection
and with the induction of vascular neoformation and
collagen deposition.
The publication results have been synthesized in Figure 2,
featuring broadly the main contributions of the LBM.
It is observed that the latex biomembrane is highly
recommended, because of the results acquired in the dif-
ferent publications. Six publications, with 128 human stud-
ies and 295 animal studies, refer to the LBM as a
vascularization-, angiogenesis-, and VEGF-inducing agent,
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Figure 3: Characterization of angiogenesis increase and VEGF. This figure is adapted from Andrade [43], public domain.
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laboratory test, and 129 animal studies) showing improve-
ments in the healing process. Nevertheless, it still presents
an antimicrobial effect, it encourages wound healing and
the adherence to recipient sclerae, and it was proven to
be as safe as a nonhypersensitivity-inducing bandage.
Frade [50] conducted clinical and immunohistopatho-
logical assessments in 21 casually selected patients, subject
to the LBM application (14 patients), in a comparison
with the classical treatment (7 patients), which consisted
of an ointment with chloramphenicol and proteolytic
enzymes (Fibrase) with the purpose of analyzing and com-
paring the histopathological and immunohistochemical
alterations when it comes to different treatments.
In order to analyze the two scenarios, the biopsies were
collected before and 30 days after Grochocki treatments.
Biopsies were then split into two fragments: one for the
immunohistopathological study and the other frozen at
-70°C for immunohistochemical analysis. The results
revealed that the use of the latex biomembrane facilitated
the Grochocki care, and it was also proven to be an ade-
quate alternative, due to its low cost and practicality of
application. It was also observed that LBM induces a clinical
and histopathological differentiation of healing points, with
improved detection of growth factors such as VEGF and
TGF1 (transforming growth factor 1).
A similar fact is evidenced in Andrade [43], where, in the
assessing of skin ulcers due to diabetes mellitus (DM) in rats,
it was found that the LBM performed as an important
healing inducer where a latex stimulus to full reepithelializa-
tion was clinically observed. This stimulating inflammatory
and oxidative stress phase favored the subsequent phases
of wound healing, enhancing angiogenesis and VEGF in
the 14th and 21st days, which certainly favored the ree-
pithelialization. It is also assumed that there was a stimu-
lus for fibroplasia in the 14th and 21st days and
collagenase, as shown in Figure 3.
Thus, the essential factors which enabled the complete
reepithelization of skin ulcers treated with F1 in diabetic
rats, showing that the biomembrane (LBM) contributed
favorably, were a larger recruitment of inflammatory cells,
stimulation of the production of growth factors and cyto-
kines, oxidative stress triggered until the 14th day, and
the important fibroplasia and collagenase stimulus as well
as the important signaling insulin activation, once reduced
in diabetics.
In Frade et al. [37], there was an evaluation of the vege-
table biomembrane’s safety as a bandage in relation to latex
hypersensitivity. Patients with cutaneous ulcers were
selected, with the groups being control: low exposure to latex
(sample = 17), high exposure to latex (sample = 14), and
ulcerated using vegetable biomembrane (sample = 13) and
experimental: ulcerated with no vegetable biomembrane
(sample = 14) and new cases (sample = 9), all submitted for
evaluation before and after 3 months using the biomem-
brane. All of them were submitted to clinical and epidemio-











Figure 4: Healing insole: (a–c) various views of the sock with the gap; (d) microporous tape glued around the gap; (e) patient using the insole
healing with tissue regeneration electronic circuit (circuit off). This figure is reproduced from Reis [42], public domain.
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contact test (“patch test”). The study concluded that the veg-
etable biomembrane was safe to be used as a bandage, as it
did not induce hypersensitivity reactions in the volunteers
submitted to the “patch test.”
In Soares et al. [51], the treatment and healing of pres-
sure ulcers using the latex biomembrane was studied, with
substantial reduction of treatment time. Reis [42] presents
the search for a new possibility for the healing of diabetic
foot ulcers. In this sense, a then-unheard-of tissue
neoformation-inducing system was developed for a diabetic
foot, with a LED light circuit and using natural latex. This
system involves a healing insole and an electronic tissue
regeneration circuit. The insole’s scarring effect is derived
from the natural latex rubber tree Hevea brasiliensis and
was individually custom made. This diabetic foot ulcer
healing method is composed of the cooperative and simul-
taneous action of both biomaterial latex and the light irra-
diation of low-intensity LED lights.
Both features have properties and agents capable of
inducing regeneration and tissue neoformation. When the
patient is using the healing insole and the tissue regeneration
electronic circuit, both of them will engage in the healing of
the diabetic foot ulcer. This happens for two reasons: full
contact of the ulcerated area with the latex and the
low-intensity LED lights irradiating on the entire extent of
the wound.
The insole’s design was one of the important require-
ments throughout this project’s preparation process. Since
this is an insole that can be used either in hospitals or in
everyday life, it is essential that it can provide the patient
with the maximum possible comfort, softness, and well-
being. Therefore, the making of this healing insole is person-
alized and individualized in its entirety, considering the
anatomy and the specific features of the patient’s foot such
as size, shape, and proportion. This allows the LED light
irradiation force cell (which is customized) to be installed
in the exact wound spot in order to promote direct healing.
In addition, customizing the insole makes it possible to per-
fectly accommodate the patient’s feet possible deformities
(foot dig or plan, bunions, claw-like fingers, and hammer,
among others) if there is any, as shown in Figure 4.
Commercially sold insoles are made following just the
numbering system and a standard model. They are not
properly built for this, even if they may accommodate
other foot health complications, and consequently, it is
nearly impossible for them to be properly useful in the
treatment of diabetic foot ulcers.
Another positive point of this invention is the low
production cost, due to the material used in the making
(biomaterial latex) and the fact that the tissue regeneration
electronic circuit consists of LED lights. This invention has
had satisfactory results, especially when it comes to reduc-
ing healing time, as demonstrated in Figures 5, 6, and 7.
In Figure 8, the black dashes belong to the control group
(CG), while the colored lines are the experimental group
(EG). As it can be seen in this figure, in the second week
of treatment, the EG’s patient 2 had presented full reepithe-







Figure 5: Photo clinical follow-up. Patient 1: control group: (a) ulcerated foot region; (b) pretreatment (initial); (c) posttreatment (1 week);
(d) 2 weeks; (e) 3 weeks; (f) 4 weeks; (g) 5 weeks; (h) 6 weeks; (i) 7 weeks; (j) 8 weeks; (k) 9 weeks. This figure is reproduced from Reis [42],
public domain.
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and 1 (CG) also presented full reepithelization in the 4th,
6th, 8th, and 9th weeks. All patients showed healing evolu-
tion in all weeks, some with less and others with more inten-
sity, except for patient 1 (CG), who in fact got worse between
the 4th and 6th weeks. When comparing the two groups in
the second week of treatment, it is possible to see that the
best UHRs belonged to the 2 patients (EG), 1 (EG), 3 (CG
and EG), and 5 (EG), while the other patients had UHRs
below 0.4. It should be noted that patient 3’s ulcer (1
ulcer-CG) was the smaller and the most superficial out of
all ulcers in this study. When making the same comparison
in week 4, it is possible to see that the highest UHRs
belonged to patients 3 (CG and EG), 1 (EG), and 5 (EG).













Figure 6: Photo clinical follow-up. Patient 2: experimental group: (a) ulcerated foot region; (b) early (before the tissue neoformation-inducing
system); (c) posttreatment (after using the tissue neoformation-inducing system) (1 week); (d) 2 weeks; (e) 3 weeks; (f) 4 weeks. This figure is
reproduced from Reis [42], public domain.
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chronic ulcer is harder to heal and has been there for the
past 16 years. Despite all that, a small evolution in the heal-
ing process of their wounds was observed.
One of the reviews of this study was a comparison of the
behavior of two different healing methods in the same
patient. This refers to the patient 1, which was submitted to
silver foam (CG) in their right foot ulcer (the metatarsals)
and a neoformation tissue inducer system (EG) on their left
foot ulcer (calcaneal region). Comparing the UHRs in both
cases in the 2nd, 4th, 6th, and 8th weeks, patient 1 presented
the best results in EG. This reveal that the tissue
neoformation-inducing system favored an increase of healing
better than foam with silver and in less time.
Costa et al. [8] made a survey on the cost of pressure ulcer
(PU) treatment, which was calculated around R$ 915.75 per
patient monthly and R$ 10,989.00 yearly in a hospital unit
in Minas Gerais. The cost for the hospital is proportionally
higher due to the number of patients that show up with PU
and due to the possibility that the available resources might
be used inappropriately. Considering the high investment
in this treatment, it is important to properly control the
materials needed in the care of PU; after all, the actions in
these treatments should aim at cost reduction, the reduction
of patient’s suffering, and the possibility to provide them with
humanized assistance.
The population with a higher risk of presenting pressure
ulcer is, in most cases, people over 60 years old, because the
skin becomes then much more sensitive due to the changes
that come with the process of aging; white people, because
“the black skin is more resistant to external damage”; the
bedridden and/or restricted-to-wheelchair people; the mal-





Figure 7: Photo clinical follow-up. Patient 3 (2 ulcer): experimental group: (a) ulcerated foot region; (b) early (before the tissue
neoformation-inducing system); (c) posttreatment (after using the tissue neoformation-inducing system) (1 week); (d) 2 weeks; (e) 3






















Figure 8: Evolution of the Ulcer Healing Rates (UHRs) in relation to the treatment time (in weeks) for the control group (CG) and the
experimental group (EG). This figure is reproduced from Reis [42], public domain.
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In Brazil, Biocure® is a registered trademark for the first
national application of latex (Biomembrane® is manufac-
tured by Pelenova Biotechnology S/A), which was founded
in 2003. According to the directors of Pelenova, Freitas and
Silva (2003), the Biocure® box with 20 units costs approxi-
mately U$ 30.00 (updated value, 2004 reference; R$ 28.50).
The similar products that come from the international
market are much more expensive because they are based on
the production of living cells, which involves very high indus-
trial effort and expenses. In Japan, this medicine costs around
U$ 500.00. Healing ointment gel with human hormone com-
pounds (Becaplermin, Johnson & Johnson) is worth nearly
U$ 350.00 and can only last for a few days of treatment. A
human skin transplant patented by Novartis costs around
U$ 1200.00, plus surgical expenses and the risk of it being
rejected by the patient’s body.
Therefore, it can be concluded that the cost for obtaining
the LBM for tissue-healing treatment is considered low when
compared with other traditional methods available on the
market that are expensive and often end up in interrupted
treatment, thus possibly worsening the patients’ situations.
5. Final Considerations
By analyzing the experiments’ results, it is possible to con-
clude that there are practical evidences of tissue healing with
the use of the latex biomembrane, including in cases of
chronic wounds from diabetes mellitus [39, 42, 43] and pres-
sure ulcers [49, 50].
There were several cases that presented tissues’ cellular
reconstitution, revascularization, and function reestablish-
ment after the burns, acting and reducing healing times in
the inflammatory phase.
LBM’s low production cost (and it is already being
manufactured in Brazil by Pelenova Biotechnology S/A
(Terenos/MS)) is another favorable aspect for this method
to be made more popular. It is more affordable than tradi-
tional methods, and it also presents favorable results in a
shorter period of time and in adverse conditions of treat-
ments for healing.
The satisfying results make it possible to elucidate that
there is still much to be studied and analyzed regarding the
LBM besides the direct use in tissue healing processes. There
is also the indirect use, with new applications, in order to take
advantage of their biocompatible material properties, which
demonstrated structural qualities (adaptability, elasticity,
impermeability, and possibility of suture) and the absence
of toxicity and allowed interaction between tissues (as dem-
onstrated by the study on vascular prostheses [40]), whether
as an inductor of sciatic nerve regeneration [35] or in ban-
dages [37] for not inducing hypersensitivity and for having
an antimicrobial effect [39].
All this considered, it is believed that the current
results, as well as the forthcoming ones, will contribute
considerably to the advancement of medicine, as well as
in the treatment of many patients by giving them a faster
healing time and an affordable cost that the majority of
the population can afford.
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